BackIntensity Therapeutics Overview

Intensity Therapeutics Total Liabilities

Intensity Therapeutics's total liabilities is $2.3M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$2.31M
↓ 15.34% YoYΔ $-419000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Intensity Therapeutics Total Liabilities History

Loading

Intensity Therapeutics vs. peers: Total Liabilities Comparison

Loading

Intensity Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Intensity Therapeutics (INTS) FAQ

Intensity Therapeutics (INTS) currently reports a total liabilities of $2.3M as of March 2026. That compares with $2.7M in the prior-year period — down 15.3% year over year. Use the charts on this page to explore Intensity Therapeutics's total liabilities history and peer comparisons.

Intensity Therapeutics's total liabilities decreased from $2.7M to $2.3M — a 15.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intensity Therapeutics reported $2.3M in total liabilities as of March 2026. That compares with $2.7M in the prior-year period — down 15.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $2.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intensity Therapeutics, and consider following INTS for alerts when major investors trade the stock.